Clinical Trials
Eating Disorders
Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa.
Interventional study. This study will compare the effectiveness of two types of psychotherapy, a relapse prevention program and cognitive behavioral therapy, in reducing relapse and fear of eating situations in people with anorexia nervosa. Ages 16-45. Location in New York, NY.
- Effectiveness of Cognitive Behavioral Therapy Plus Nutritional Counseling in Promoting Weight Loss in People With Binge Eating Disorder.
Interventional study. This study will evaluate the effectiveness of adding nutritional counseling to cognitive behavioral therapy in treating obese people with binge eating disorder. Ages 21-60. Location in New Haven, CT.
- Effectiveness of Cognitive Remediation Therapy in Improving Treatment Retention in People With Anorexia Nervosa.
Interventional study. This study will evaluate the effectiveness of adding cognitive remediation therapy to cognitive behavioral therapy for treating people with anorexia nervosa. Ages 18 and over. Location in Stanford, CA.
- Pharmacogenomics of Antidepressant Response in Children and Adolescents.
Evaluation study. This study will identify variations in genes that may be involved in the development of suicidal events or certain behaviors in youth who are exposed to antidepressant medications. Ages 7-17. Location in Durham, NC.
- Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa.
Interventional study. This study will compare the effectiveness of two types of cognitive behavioral therapy in treating adult women with the dysregulated subtype of bulimia nervosa. Ages 18-65. Location in Boston, MA.
- Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents.
Interventional study. This study will compare the effectiveness of two therapies to treat early signs of anorexia nervosa in adolescents. Ages 10-17. Location in New York, NY.
- Antidepressant Safety in Kids Study.
Evaluation study. This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder. Ages 7-17. Location in Durham, NC.
- Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders.
Evaluation study. This study will use a sipping and spitting exercise to better understand the brain's response to food intake in people with eating disorders. Ages 16-45. Location in New York, NY.
- An fMRI Study of Self-Regulation in Adolescents With Bulimia Nervosa.
Evaluation study. The aim of this project is to use both functional MRI (fMRI) and behavioral measures to investigate how disturbances in frontostriatal neural systems contribute to the impulsive and habitual binge-eating behaviors in patients with Bulimia Nervosa (BN). Ages 12-21. Location in New York, NY.
- Amino Acids, Serotonin, and Body Weight Regulation.
Interventional study. This study will assess the behavioral effects of an amino acid mixture thought to influence serotonin function in individuals who have recovered from anorexia nervosa. Ages 18-40. Location in Boston, MA.
- Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa.
Evaluation study. This study will compare the concentrations of serotonin transporter in the brains of women with a history of anorexia nervosa who are currently maintaining a normal weight to those of healthy women of normal weight. Ages 18-45. Location in New York, NY.
- Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa.
Interventional study. This study will determine the effectiveness of administrating a dose of cholecystokinin during a binge eating episode in reducing this eating behavior in people with bulimia nervosa. Ages 18-55. Location in New York, NY.
- Hormone Release and Stomach Disturbances in People With Binge Eating Disorder.
Evaluation study. This study will determine whether the disturbances in cholecystokinin release and gastric emptying that occur in people with binge eating disorder are similar to those that occur in people with bulimia nervosa. Ages 18-60. Location in New York, NY.
- Motivating Factors That Play a Role in Bulimia Nervosa.
Evaluation study. This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs. Ages 18-45. Location in New York, NY.
- Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in People With Bulimia Nervosa.
Interventional study. This study will determine the effectiveness of the antibiotic erythromycin in enhancing gastrointestinal function and decreasing the frequency of binge eating in people with bulimia nervosa. Ages 18-55. Location in New York, NY.
- Effectiveness of a Normalization of Eating Intervention Program for Treating Women With Eating Disorders.
Interventional study. This study will evaluate the effectiveness of a new approach to a normalization of eating program, based on principles of cognitive-behavioral therapy, in treating women with anorexia nervosa or bulimia nervosa. Ages 15-40. Location in Radnor, PA.
Search ClinicalTrials.gov for other NIH studies on Eating Disorders.
